Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.11 USD | +0.74% | -0.56% | +4.71% |
03-18 | Harte Hanks, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
03-14 | Transcript : Harte Hanks, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Strengths
- With a P/E ratio at 14.08 for the current year and 6.77 for next year, earnings multiples are highly attractive compared with competitors.
- The stock, which is currently worth 2024 to 0.16 times its sales, is clearly overvalued in comparison with peers.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Advertising & Marketing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.71% | 51.52M | - | ||
-15.12% | 1.86B | B- | ||
-17.50% | 561M | - | - | |
+11.87% | 390M | - | - | |
-28.16% | 383M | - | - | |
+28.71% | 184M | C | ||
+18.69% | 121M | - | - | |
+6.82% | 97.36M | - | - | |
-56.54% | 96.35M | - | - | |
+66.04% | 93.53M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- HHS Stock
- Ratings Harte Hanks, Inc.